Quantcast

Latest Psoriatic arthritis Stories

2014-10-20 16:27:09

- Biologics License Application (BLA) for secukinumab, a "first-in-class" IL-17A inhibitor, is currently under FDA review with an anticipated action date in early 2015 EAST

2014-10-17 23:02:09

A California man filed a class action lawsuit against Immunex and Caremark CVS alleging that the pharmacy fails to properly refrigerate best-selling drug Enbrel when filling a mail order Caremark

2014-10-13 08:27:34

Be Joint Smart to educate roughly 28,000 local residents with PsA about their disease PORTLAND, Ore., Oct.

2014-10-08 16:23:50

Be Joint Smart to educate roughly 23,200 local residents with PsA about their disease PORTLAND, Ore., Oct.

2014-09-30 08:31:47

Be Joint Smart to educate roughly 35,000 local residents with PsA about their disease PORTLAND, Ore., Sept.

2014-09-23 08:30:57

Be Joint Smart to educate roughly 150,000 local residents with PsA about their disease PORTLAND, Ore., Sept.

2014-09-08 12:24:27

TNF-Alpha Inhibitors--Including Sales Leader Humira--Accounted for Over 90 Percent of the Psoriatic Arthritis Market, According to Findings from Decision Resources Group BURLINGTON, Mass.,


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.